{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:59:15Z","timestamp":1785419955020,"version":"3.56.0"},"reference-count":29,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","award":["209558"],"award-info":[{"award-number":["209558"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2123180","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T14:36:10Z","timestamp":1666794970000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers\u2019 attitudes and practices"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-999X","authenticated-orcid":false,"given":"Oscar","family":"Herrera-Restrepo","sequence":"first","affiliation":[{"name":"US Health Outcomes, Vaccines, GSK, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-3433","authenticated-orcid":false,"given":"Kimberly","family":"Davis","sequence":"additional","affiliation":[{"name":"Surveys and Observational Studies, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-5893","authenticated-orcid":false,"given":"Carolyn","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Surveys and Observational Studies, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-7000","authenticated-orcid":false,"given":"Eric","family":"Davenport","sequence":"additional","affiliation":[{"name":"Biostatistics, RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-5590","authenticated-orcid":false,"given":"Parinaz","family":"Ghaswalla","sequence":"additional","affiliation":[{"name":"US Health Outcomes, Vaccines, GSK, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-3669","authenticated-orcid":false,"given":"Philip O.","family":"Buck","sequence":"additional","affiliation":[{"name":"US Health Outcomes, Vaccines, GSK, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"CDC. Vaccine-preventable adult diseases. [accessed 2021 Jul 30]. https:\/\/www.cdc.gov\/vaccines\/adults\/vpd.html."},{"key":"e_1_3_6_3_1","unstructured":"CDC. Widespread outbreaks of hepatitis A across the U.S. [accessed 2021 Jul 30]. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2017March-HepatitisA.htm."},{"key":"e_1_3_6_4_1","unstructured":"CDC. Hepatitis A surveillance in the United States for 2019. [accessed 2021 Jul 30]. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/HepA.htm."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6818a2"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz788"},{"key":"e_1_3_6_7_1","unstructured":"CDC. Hepatitis B surveillance in the United States for 2019. [accessed 2021 Jul 30]. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/HepB.htm."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7003a1"},{"key":"e_1_3_6_9_1","unstructured":"CDC. The healthy people 2010 database - October 2011 edition. [accessed 2021 Aug 26]. https:\/\/wonder.cdc.gov\/scripts\/broker.exe?_SERVICE=default&_PROGRAM=HP2010.INC.SAS&_DEBUG=0&focus=&related=&sg=0&clfiles=BLY+BSL+Y98+Y99+Y00+Y01+Y02+Y03+Y04+Y05+Y06+Y07+Y08+Y09+Y10+TRG&srcenote=Y&footnote=Y&errsw=0&progname=OBJ&b=1&obj=14-28a&race=&source=&gender=&rm=&st=0&tr=&ato=0."},{"key":"e_1_3_6_10_1","volume-title":"Viral hepatitis national strategic plan: a roadmap to elimination for the United States (2021\u20132025)","author":"HHS.","year":"2020","unstructured":"HHS.Viral hepatitis national strategic plan: a roadmap to elimination for the United States (2021\u20132025). Washington, D.C; 2020."},{"key":"e_1_3_6_11_1","unstructured":"CDC. Recommended adult immunization schedule for ages 19 years or older. 2022 [accessed 2022 May 25]. https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-combined-schedule.pdf."},{"key":"e_1_3_6_12_1","unstructured":"Recommended Adult Immunization Schedule. 2021. https:\/\/stacks.cdc.gov\/view\/cdc\/102666."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6920a4"},{"issue":"4","key":"e_1_3_6_14_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nurpra.2021.12.028","article-title":"Knowledge, practices and perceived barriers to hepatitis A and B vaccination guidelines: a survey of United States healthcare providers","volume":"18","author":"Ghaswalla P","year":"2022","unstructured":"Ghaswalla P, Davis K, Sweeney C, Davenport E, Trofa A, Herrera-Restrepo O, Buck PO, et al. Knowledge, practices and perceived barriers to hepatitis A and B vaccination guidelines: a survey of United States healthcare providers. J Nurse Pract. 2022;18(4).","journal-title":"J Nurse Pract"},{"key":"e_1_3_6_15_1","unstructured":"M3 Global Research. [accessed 2021 June]. https:\/\/www.m3globalresearch.com\/."},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.92.5.778"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41271-021-00293-y"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229681200600417"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1"},{"key":"e_1_3_6_21_1","unstructured":"Vaccines National Strategic Plan for the United States (2021\u20132025)"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7113a1"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.035"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000334"},{"key":"e_1_3_6_25_1","unstructured":"CDC. Outbreak-Specific considerations for hepatitis a vaccine administration. Hepatitis A Outbreaks; 2020 [accessed 2022 May 25]. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/InterimOutbreakGuidance-HAV-VaccineAdmin.htm."},{"key":"e_1_3_6_26_1","unstructured":"CDC. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. 2020. [accessed 2021 Aug 20]. https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6905a1.htm."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3316"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2020.11.013"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.056"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.03.011"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2123180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:41:42Z","timestamp":1737049302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2123180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2123180"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2123180","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2123180"}}